Revolutionary ‘Bone Glue’ Heals Fractures in Minutes, Not Months

Researchers in China have developed a groundbreaking adhesive called Bone-02, capable of repairing fractures in as little as three minutes. This innovative bio-adhesive, which naturally dissolves as the bone heals, promises to transform fracture treatment worldwide by offering a safer, faster alternative to traditional metal plates and screws.

The creation of Bone-02 stems from nearly a decade of meticulous research at the Zhejiang University School of Medicine and Xiaoshan Hospital. Inspired by the adhesive qualities of oysters, this biodegradable glue is designed to bond bone fragments even in challenging, blood-rich environments. Lead investigator Professor Pan Xunwu highlighted the limitations of conventional fracture repairs, which often lead to complications such as lost bone fragments, delayed recovery, and the need for secondary surgeries.

“Bone fragments were often lost, reducing bone mass and ultimately negatively impacting patients’ quality of life,” he explained to Chosun Ilbo.

Promising Results from Clinical Trials

The efficacy of Bone-02 has been demonstrated in clinical trials involving over 150 patients. In one notable case, a patient with a comminuted wrist fracture had their bone fragments secured in just three minutes through a small incision measuring 2–3 cm. Traditional methods would typically require a much larger incision and a follow-up surgery for removal a year later. Remarkably, after three months, the patient’s wrist function was fully restored without any complications.

The adhesive exhibits impressive mechanical properties, including a tensile strength capable of withstanding over 181 kg, a compressive strength of approximately 10 MPa, and a shear strength of around 0.5 MPa. These metrics suggest that Bone-02 could rival or potentially replace existing metal implants, as noted by Global Times.

Potential Impact on Orthopaedic Medicine

According to Lin Xianfeng, associate chief orthopaedic surgeon at Sir Run Run Shaw Hospital and co-lead researcher, Bone-02 could significantly alter the landscape of fracture treatment. The adhesive’s rapid bonding capabilities and its ease of use may not only shorten surgery times but also reduce intraoperative damage.

Historically, attempts to create effective bone adhesives date back to the 1940s, with previous methods involving gelatin, epoxy resins, and acrylates being abandoned due to issues with biocompatibility and strength. With Bone-02, the researchers believe they have addressed these longstanding challenges.

Currently, Bone-02 is undergoing multi-centre randomized controlled clinical trials, which are essential for regulatory approval. If these trials yield positive results, the adhesive could be available in hospitals worldwide within the next few years. Medical professionals remain cautiously optimistic, emphasizing the need for peer-reviewed studies and adherence to international safety benchmarks.

With early evidence suggesting that Bone-02 could be a revolutionary advancement in orthopaedic medicine, millions of fracture patients may soon have access to a treatment that offers a quicker, safer path to recovery.